Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Julie Chang, MD
University of Wisconsin, Madison
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bellin Memorial Hospital
Green Bay, Wisconsin, United States
- St Vincent Regional Cancer Center
Green Bay, Wisconsin, United States
- Mercy Health System Heme/onc
Janesville, Wisconsin, United States
- Gundersen Clinic
La Crosse, Wisconsin, United States
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
- Marshfield Clinic
Marshfield, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
- Oconomowoc Memorial Hospital
Oconomowoc, Wisconsin, United States
- Waukesha Memorial Hospital
Waukesha, Wisconsin, United States
- Riverview Hospital
Wisconsin Rapids, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2009
- Primary completion
- 31 Jul 2013
- Completion
- 30 Apr 2015
- Last update posted
- 2 Dec 2019
- Registered enrollment
- 34
- Registry id
- NCT00974233
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.